Puma AG Rudolf Dassler Sport (PUM-FF)

QUOTE AND NEWS
SeekingAlpha  Apr 9  Comment 
ByJustin Jaynes: Fellow Seeking Alpha contributor Alcaraz Research surmised that free Microsoft (MSFT) 8.1 licensing for small form factor tablets could be a tail wind for Advanced Micro Devices (AMD), spurring on growth of the gaming tablet. His...
Benzinga  Apr 7  Comment 
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, today announced the presentation of positive results from the Phase II clinical trial of Puma's investigational drug PB272 (neratinib) for the neoadjuvant...
FierceBiotech  Apr 7  Comment 
Puma Biotechnology is boasting that its experimental cancer drug neratinib bested Herceptin in a head-to-head study of HER2-positive breast cancer when used ahead of surgery.
New York Times  Apr 4  Comment 
Scores of garment workers have fallen sick this week at factories in Cambodia, including two that produce clothing for the sportswear groups Puma and Adidas, workers and the companies said Thursday.     
SeekingAlpha  Apr 3  Comment 
By Alpha Now at Thomson Reuters: By Steven Carroll, Independent Commentator In just over two months, Brazil meets Croatia in the opening match of that global obsession known as the football (soccer to Americans) World Cup. With the...
The Hindu Business Line  Apr 3  Comment 
How Puma became India’s No. 2 athletic wear brand by spending less, owning more
DailyFinance  Mar 27  Comment 
RIMOUSKI, QUEBEC -- (Marketwired) -- 03/27/14 -- Puma Exploration (TSX VENTURE:PUM) has started a drill program on 12 exploration targets on its 100-per-cent-owned Nicholas-Denys project in New Brunswick. These exploration targets were defined by...
newratings.com  Mar 27  Comment 
Puma High Income VCT plc 27 March 2014 Puma High Income VCT plc ("the Company") As at the close of business on 28 February 2014, the estimated Net Asset Value per ordinary share ("NAV per share") of the Company was 66.10p.  This represents a ...
SeekingAlpha  Mar 13  Comment 
ByPoonam A. Arora: Investment Thesis Puma Biotechnology (PBYI) is an oncology focused biotech company. Its lead asset Neratinib is being developed in several programs, the most advanced being a Phase III in 2nd/3rd line HER2+ metastatic...




 
TOP CONTRIBUTORS

Puma AG (FRA:PUM, PINK:PMMAY) is a holding company based in Herzogenaurach, Germany that manufactures athletic footwear, apparel, equipment, and accessories through brands such as Puma and Tretorn. Puma also produces a collection of fashion footwear and apparel. Puma AG makes money in several ways. First, it sells its products to traditional retailers such as Foot Locker (FL) and Thyai Dunn also performed in a print ad for Russell AthleticsDick's Sporting Goods (DKS) at wholesale price (83% or 2007 revenue). However, Puma also sells directly to consumers via its website, concept and retail stores, and factory outlets (17% of total sales in 2007). At the end of 2007, the company ran 116 concept stores worldwide.[1]

Since margins are typically higher on retail sales as opposed to wholesale, Puma is also working to expand its retail operations, which generated €406.4 million in sales during 2007, up 18% from 2006.[2] These expansion plans cost money, however, which has taken a bite out of Puma's net income. For example, although sales grew from €2.4 billion to €2.8 billion between 2005 and 2006, net income actually fell from €285.8 million to €263.2 million because of increases in marketing, retail, and personnel expenses.[3] Though free cash flow may suffer in the meantime, Puma is betting that the upfront costs will pay off in the long run.

Company Overview

Puma AG earns revenue by selling its footwear to retailers and specialty shops and directly to consumers through its website or retail stores. The company manufactures athletic footwear (€1.4 billion, or 58.5% of 2007 revenue), apparel (€827.3 million, or 34.8%), and accessories (€158.3 million, or 6.7%) under four different brands:Puma, Tretorn, Mihara, and Rudolf Dassler Schuhfabrik.[4][5] Additionally, Puma earns a small amount (€35.6 million in 2007) from licensing royalties and commissions.

Puma AG's 2007 revenue totaled €2.74 billion, which was essentially flat from 2006's revenue of €2.76 billion. However, this slight (0.6%) drop can be attributed to foreign currencies weakening against the euro (primarily the U.S. dollar and several Asian currencies). Other than that small drop in 2007, Puma's sales have increased every year since 1993, when revenues totaled €541.3 million.

As Puma's sales have grown, so have its expenses. Expenses for marketing and retail, which totaled €272 million in 2005, came to about €420 million in both 2006 and 2007.[6] Overall operating expenses increased by nearly 50% between 2005 and 2006, causing Puma's net income for 2006 to fall 8% despite a 15% increase in revenue.

Error creating thumbnail
Puma 2007 Annual Report Financial[7]
Error creating thumbnail
Puma 2007 Annual Report Financial[8]


Income Statement 2002 2003 2004 2005 2006 2007
Revenue€1,3801,691.52,016.62,3872,755.12,738.8
Expenses€252.3320.4414.9513.4742760.4
Net Income€84.9179.3258.7285.8263.2269
Profit Margin6.2%10.6%12.8%12.0%9.6%9.8%

Trends and Forces

Error creating thumbnail
Puma 2007/2006/2005 Annual Report Financial[9]

Emerging markets fueling growth

Since it is a German company and does the largest part of its business in EMEA (Europe, the Middle East, and Africa), Puma is not as dependent on the U.S. market as some of its competitors. Only 25.3% of its 2007 sales came from the Americas region (down from 28.3% in 2006), which also consists of the Canadian and Mexican markets.[10] In addition, Puma AG is aggressively pursuing expansion opportunities in emerging markets as part of its growth strategy. For example, the company established fully owned subsidiaries in South Korea, Croatia, and Romania that became operational at the start of 2008.[11] Even before that, the Asia/Pacific region alone had sales growth of 147.8% in 2006 and more than 10% in 2007.

Backlogs, which are orders set to ship within the next 6 months, paint a similar picture. At the end of FY2007, Puma AG had a backlog of €1.2 billion, up 6.1% from the end of FY2006; this was the twelfth year in a row that Puma's backlog increased year-over-year. This increase came despite a 3.2% drop in backlog in the Americas region (caused by the sluggish U.S. market), as the decrease was offset by backlog growth of 26% in the Asia/Pacific region.[12]

PPR SA owns 62% of Puma's stock

In April of 2007, PPR SA (EPA:PP), a French holding company that specializes in retail and luxury brands, bought a 27% stake in Puma AG for €330 per share and offered to buy the entire company for €5.3 billion, leading to speculation about the possibility of a complete takeover.[13] Puma declined the offer, however, and remains its own company. On July 17, 2007, PPR SA announced that it had acquired a total of 62.1% of Puma AG's outstanding stock.[14] Though it doesn't own Puma AG, PPR does control the majority of stockholder voting rights, meaning that it has a substantial amount of influence over any issues put to a shareholder vote.

Competition & Market Share

For comparison purposes, Puma had 2007 revenues of roughly €2.8 billion ($3.8 billion using the average 2007 exchange rate).[15]

  • Nike (NKE): 2007 revenue - $16.3 billion. Nike competes with the Puma on all fronts: footwear, apparel, accessories, and equipment. Nike is also the largest sporting goods company in the world by sales.
  • Adidas AG (ADDYY): 2007 revenues - $13.7 billion. The adidas Group competes in the overall sporting goods market. It makes sports footwear, apparel, accessories, and equipment. Like Nike, the adidas Group is also much larger than Puma in terms of sales.
  • Columbia Sportswear Company (COLM) 2007 revenue - $1.35 billion. Columbia Sportswear designs and sells athletic and outdoor apparel, footwear, accessories, and equipment.
  • Under Armour (UA): 2007 revenue - $600 million. Under Armor designs and sells athletic footwear, apparel, and accessories. Under Armor's sales have grown rapidly, with a 5-year sales growth rate of 65% from 2002-2007 (the industry average was 15%). [16]

This pie chart on the left shows that Puma held roughly 7% of the global athletic footwear market in 2007, while the one on the right shows that Puma held 2% of the global athletic apparel market in the same time period.

Error creating thumbnail
Commerzbank Equity Research[17]
Error creating thumbnail
Commerzbank Equity Research[18]

References

  1. Puma 2007 Annual Report Financial pg. 9, "Expansion of Own Retail Operations as Expected"
  2. Puma 2007 Annual Report Financial pg. 9, "Expansion of Own Retail Operations as Expected"
  3. Puma 2007 Annual Report Financial pg. 2, "Puma Group Development"
  4. PPR Group, "Puma"
  5. Puma, "Our Brands"
  6. Puma 2007 Annual Report Financial pg. 2, "Puma Group Development"
  7. Puma 2007 Annual Report Financial pg. 2, "Puma Group Development"
  8. Puma 2007 Annual Report Financial pg. 2, "Puma Group Development"
  9. Puma 2007/2006/2005 Annual Report Finance pgs. 9/19/6, "Business Development"
  10. Puma 2007/2006 Annual Report Financial pg. 9/19, "Business Development"
  11. Puma AG Investor Relations, "Letter to the Shareholders"
  12. Puma 2007 Annual Report Financial pg. 22, "Orders Position"
  13. Pinault refuses to raise PPR's bid for Puma - International Herald Tribune
  14. Wikipedia, "Puma AG"
  15. Monthly Average Graph (American Dolla, Euro) 2007
  16. Reuters.com, "Under Armor Ratios"
  17. Christoph Dolleschal, "adidas," Equity Research, Commerzbank, 28 February 2008
  18. Christoph Dolleschal, "adidas," Equity Research, Commerzbank, 28 February 2008
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki